
Atenolol or Bisoprolol after Myocardial Infarction without Recorded Heart Failure
Using French national health data on 11,558 patients treated in the Paris area after a myocardial infarction and with no sign of heart failure, the team compared the two most prescribed beta-blockers. Starting atenolol was associated with fewer major cardiovascular events at two years than bisoprolol, without a significant difference in overall mortality.
Subgroup analysis from Laurenceau et al., NEJM Evidence 2026 — © Massachusetts Medical Society.
Read the article →





